I Love Lund (LOVE) Q2 2026 earnings summary

Executive summary

• Net sales remained at 0 TSEK for both the quarter and half-year, unchanged year-over-year.

• Operating result improved slightly to -825 TSEK for the quarter and -1.7 MSEK for the half-year.

• Profit after financial items rose to 518 TSEK for the quarter and 78 TSEK for the half-year, reflecting successful exits and investment activities.

• High transaction activity included profit-taking in BeammWave, new investments in Valkyr Defense, and the acquisition of Saga Diagnostics.

Financial highlights

• Operating result for Q2: -825 TSEK (vs. -837 TSEK prior year); half-year: -1.7 MSEK (vs. -1.6 MSEK).

• Financial items including write-downs: 343 TSEK for Q2 (vs. -1,048 TSEK); 1.7 MSEK for half-year (vs. -2.4 MSEK).

• Result after financial items: 518 TSEK for Q2 (vs. 211 TSEK); 78 TSEK for half-year (vs. -4,022 TSEK).

• Earnings per share: 1.2 SEK for Q2 (vs. 0.49 SEK); equity per share at period end: 82.1 SEK (vs. 83.65 SEK).

• Substantiated value per share at period end: 108.59 SEK.

Outlook and guidance

• Improved macroeconomic and interest rate environment supports selective market segments.

• Continued focus on early-stage, unlisted companies with reinvestment of realized gains.

• Anticipated business milestones in portfolio companies, including potential partner deals and global expansion.